Odulimomab

Tax included
Odulimomab (anti-LFA1) is an anti-LFA-1 monoclonal antibody. Odulimomab inhibits proliferation of T lymphocyte and shows protective effects against ischemia and reperfusion injury. Odulimomab can be used for the research of transplant rejection and immunological disease.
HY-P99765

Data sheet

Size
Multiple sizes
Reactivity
Integrin
Application
COVID-19-immunoregulation
CAS
159445-64-4